Nicomac Mangini Introduces ANIMA: The Future Of AI-Driven Pharmaceutical Process Optimization at CPHI Milan 2024

Milan, Italy – September 2024 – Nicomac Mangini is set to reshape the pharmaceutical manufacturing industry with the launch of ANIMA, the first advanced AI application integrated into machines for oral solid dosage processes. ANIMA will be launched at CPHI Milan 2024 from October 8 to 10, where attendees can see live demonstration of its innovative capabilities in optimising production processes.

ANIMA, "Artificial Intelligence Nicomac Mangini, " is a state-of-the-art AI platform, specifically designed to assess past production processes, optimise future ones, and create standard reference processes for the pharmaceutical industry. Through its integration with a digital twin, it enables manufacturers to simulate and fine-tune their production workflows before real-world operations implementation, helping ensure efficiency and accuracy at every step of the way. The AI platform goes beyond optimization, as ANIMA further offers manufacturers complete control over the production process through its Digital Assistant, which monitors real-time variables.

Key Features of ANIMA:

• Real-Time Monitoring: ANIMA’s  digital assistant keeps track of all the production variables and provides instant feedback in order to maintain ensuring optimal operational conditions.

• Digital Twin Simulation: ANIMA’s digital twin feature enables the simulation of production processes, that allows operators to recognize inefficiencies and optimise parameters before the beginning of the production process.

• Automatic Process Control: ANIMA’s auto pilot mode takes charge of the production, making sure that each process runs at peak efficiency. 

• Continuous Learning: With every single use, ANIMA learns and updates its vast database continuously, refining its processes and becoming even more smarter over time.

Valerio Mantuano, Area Manager at Nicomac Mangini, stated, “We believe that ANIMA marks the beginning of a new chapter for pharmaceutical production. Our aim with ANIMA is to bring the pharmaceutical industry into the next era of intelligent manufacturing. By integrating AI into every step of the production process, we offer manufacturers with unprecedented insight and control, supporting them to achieve higher efficiency & quality, and more reliable outcomes.

How ANIMA Benefits Manufacturers:

• Boosts Efficiency: By reducing downtimes and streamlining operations, ANIMA makes pharmaceutical production faster and even more efficient.

• Superior Quality: AI-driven optimization as well as analysis guarantees that every batch meets the same high standards.

• Lower Operational Costs: By reducing errors and optimizing processes, ANIMA helps cut costs and maximize profitability.

• Innovative & Adaptive: ANIMA’s  machine learning capabilities means it evolves continuously, offering manufacturers with personalized and forward thinking solutions.

Experience ANIMA In Action At CPHI Milan 2024

Nicomac Mangini is inviting industry professionals to experience ANIMA first-hand at CPHI Milan 2024. Attendees can visit “Stand #18C26 from October 8 to 10, where live demonstrations will highlight the ability of the platform to transform pharmaceutical production. 

For media inquiries, appointments for demonstrations, or more information on ANIMA, Book Appointment here : Book Appointment at CPHI Milan 2024 OR please contact:

Marketing Team
Nicomac Mangini
Email: barbara.ainis@nicomac.it
Phone: +393931861459
Website: https://nicomac.com/

About Nicomac Mangini:

Nicomac Mangini is a leader in developing innovative solutions and has long been at the forefront in pharmaceutical and nutraceutical industries. Known for its decades of experience and a commitment to pioneering modernistic technologies, the company truly continues to push the boundaries of what's possible in manufacturing.